Abstract
Background
Dupuytren’s disease is described as a thickening of the palmar fascia. It typically affects men of Northern European descent in their fifties. The disease process starts as a nodule at the distal palmar crease that progressively gives rise to a cord invading distally toward the finger. Historically, different treatments have been described. Our purpose was to perform a meta-analysis of the evidence published on the percutaneous fasciotomy (PCF) treatment.
Methods
We searched Medline, PubMed, and the Cochrane Library for articles evalu ating the use of PCF for Dupuytren’s disease. No study was excluded based on quality.
Results
The search yielded nine studies. Because of their different methodologies, a meta-analysis could not be performed. However, we were able to extract common qualitative conclusions. PCF is an effective treatment modality for patients in whom general anesthesia is contraindicated, with a good outcome especially at the metacarpophalangeal joint, a low recurrence rate in the short term, and few complications.
Conclusions
Similar conclusions were reached by all the articles under study. Nevertheless, there remains the need for a prospective study with a higher statistical power and standardized clinical evaluation and surgical methods in order to achieve more objective quantitative results. It would also be pertinent to compare the outcomes and complication rates of PCF with the new collagenase treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bryan AS, Ghorbal MS. The long-term results of closed palmar fasciotomy in the management of Dupuytren’s contracture. J Hand Surg. 1988;13B(3):254–6.
Caufield RJ, Edwards SG. Dupuytren disease: an update on recent literature. Curr Orthop Pract. 2008;19(5):499–502.
Cheng HS, Hung LK, Tse WL, Ho PC. Needle aponeurotomy for Dupuytren’s contracture. J Orthop Surg. 2008;16(1):88–90.
Colville J. Dupuytren’s contracture—the role of fasciotomy. Hand. 1983;15(2):162–6.
Duthie RA, Chesney RB. Percutaneous fasciotomy for Dupuytren’s contracture—a 10-year review. J Hand Surg. 1997;22B(4):521–2.
FDA. Protecting and promoting your health [Internet]. Silver Spring: US Food and Drug Administration. Collagenase, 9 Aug 2010 [about 2 screens]. http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm221281.htm. Accessed 13 Nov 2010.
Foucher G, Medina J, Malizos K. Percutaneous needle fasciotomy in Dupuytren disease. Tech Hand Up Extrem Surg. 2001;5(3):161–4.
Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg. 2003;28B(5):427–31.
Lee MVK, Hunter-Smith D. Needle fasciotomy for Dupuytren’s disease: an Australian perspective. ANZ J Surg. 2009;79(11):776–778.
Rowley DI, Couch M, Chesney RB, Norris SH. Assessment of percutaneous fasciotomy in the management of Dupuytren’s contracture. J Hand Surg. 1984;9B(2):163–4.
Shaw RB, Chong AKS, Zhang A, Hentz VR, Chang J. Dupuytren’s disease: history, diagnosis, and treatment. Plast Reconstr Surg. 2007;120(3):44–54.
Thorne CH, Beasly RW, Aston SJ, Bartlett SP, Gurtner GC, Spear SL. Grabb and Smith’s plastic surgery. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 864–5.
Van Rijssen AL, Werker PMN. Percutaneous needle fasciotomy in Dupuytren’s disease. J Hand Surg. 2006;31B(5):498–501.
Weinzweig J. Plastic surgery secrets. Philadelphia: Elsevier; 1999. p. 554–9.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Salhi, S., Cardin-Langlois, E. & Luc, M. Percutaneous fasciotomy for the treatment of Dupuytren’s disease—a systematic review. HAND 6, 349–355 (2011). https://doi.org/10.1007/s11552-011-9355-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11552-011-9355-3